Shifting from cytology to HPV testing for cervical cancer screening in Canada
Emily Delpero, Amanda Selk
Abstract
KEY POINTS Infection with high-risk strains of the human papillomavirus (HPV) is a known prerequisite for developing cervical cancer.[1][1] Soon, a test for high-risk strains of HPV will replace the Papanicolaou (Pap) test for routine cervical cancer screening in Canada. Unlike the Pap test, which
Topics & Concepts
Papanicolaou stainCervical cancerPapanicolaou TestHuman papillomavirusMedicineGynecologyPap testCytologyTest (biology)Cervical cancer screeningPapillomaviridaeCancerCancer screeningObstetricsPathologyInternal medicineBiologyPaleontologyCervical Cancer and HPV ResearchGlobal Cancer Incidence and Screening